Meeting Coverage:

American Academy of Ophthalmology

AAO: 2019

The Latest Trends in Dry Eye Disease Management

Show Description +

Audrey R. Talley Rostov, MD, reviews the latest updates on the medical and surgical management of dry eye disease. She focuses on the trends happening in the disease subtypes—anterior and posterior blepharitis, meibomian gland dysfunction, aqueous deficiency, and other co-conspirators.

Posted: 10/02/2019

Up Next

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS


PANORAMA Study Data

Rishi P. Singh, MD

Gene Therapy for Wet AMD

Szilard Kiss, MD

ABC to Block VEGF-A Isoforms

Charles C. Wykoff, MD, PhD

Surgery for Viral Retinitis

J. Fernando Arevalo, MD, PhD, FACS

Iridocorneal Endothelial Syndrome

Lauren S. Blieden, MD

Advanced Diagnostics in Refractive Surgery: Epithelial Mapping and Phakic IOL Sizing

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Efficacy of Presbyond for the Correction of Presbyopia

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Autonomous AI in Ophthalmology

Michael D. Abramoff, MD, PhD

CXL for Infectious Keratitis

Farhad Hafezi, MD, PhD, FARVO

MIGS and Medications

Alex Huang, MD

Controlling Wound Healing Following PRK

Farhad Hafezi, MD, PhD, FARVO

The Latest Trends in Dry Eye Disease Management

Audrey R. Talley Rostov, MD, reviews the latest updates on the medical and surgical management of dry eye disease. She focuses on the trends happening in the disease subtypes—anterior and posterior blepharitis, meibomian gland dysfunction, aqueous deficiency, and other co-conspirators.

Posted: 10/02/2019


Please log in to leave a comment.

Comments

Michael Gross

5 years ago

Dr. Rostov's review almost totally ignores the MGD component of the Dry Eye Disease problem. How can we call this a comprehensive review of therapeutic options when meibum quality is not included? The use of a therapeutic dose of rTG Omega-3s as an "inside-out" systemic treatment for DED to create quality meibum MUST be included as necessary adjuvant therapy in this regard.

More From AAO: 2019 Coverage

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS